We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$47.2B
AUM Growth
+$8.08B
Cap. Flow
+$2.33B
Cap. Flow %
4.95%
Top 10 Hldgs %
35.89%
Holding
5,834
New
1,032
Increased
1,743
Reduced
1,554
Closed
961

Sector Composition

Rank Sector Weight
1 Technology 2.27%
2 Financials 2.09%
3 Healthcare 1.72%
4 Consumer Discretionary 1.48%
5 Industrials 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMB icon
3601
CALL
Trimble
TRMB
$13.2B
$202K ﹤0.01%
3,800
-21,700
-85% -$1.03M
DOX icon
3602
CALL
Amdocs
DOX
$5.92B
$202K ﹤0.01%
2,300
+700
+44% +$58.3K
IWN icon
3603
PUT
iShares Russell 2000 Value ETF
IWN
$14.3B
$202K ﹤0.01%
1,300
-600
-32% -$83.1K
ENS icon
3604
PUT
EnerSys
ENS
$6.78B
$202K ﹤0.01%
+2,000
New +$184K
MAXN
3605
PUT
DELISTED
Maxeon Solar Technologies
MAXN
$201K ﹤0.01%
281
+150
+115% +$97.8K
BCC icon
3606
Boise Cascade
BCC
$2.69B
$201K ﹤0.01%
1,551
-10,671
-87% -$1.14M
SKM icon
3607
SK Telecom
SKM
$12.1B
$201K ﹤0.01%
9,374
-2,544
-21% -$53.8K
RDN icon
3608
PUT
Radian Group
RDN
$5.18B
$200K ﹤0.01%
+7,000
New +$184K
ARCH
3609
CALL
DELISTED
Arch Resources, Inc.
ARCH
$199K ﹤0.01%
1,200
+1,100
+1,100% +$173K
ONC
3610
CALL
BeOne Medicines Ltd
ONC
$32.8B
$198K ﹤0.01%
1,100
+500
+83% +$90.5K
AVXL icon
3611
PUT
Anavex Life Sciences
AVXL
$255M
$198K ﹤0.01%
+21,300
New +$147K
BTU icon
3612
Peabody Energy
BTU
$2.6B
$198K ﹤0.01%
8,150
-203,361
-96% -$4.9M
ICLR icon
3613
CALL
Icon
ICLR
$12.6B
$198K ﹤0.01%
700
-4,600
-87% -$1.19M
OLMA icon
3614
CALL
Olema Pharmaceuticals
OLMA
$1B
$198K ﹤0.01%
14,100
+700
+5% +$9.41K
CP icon
3615
CALL
Canadian Pacific Kansas City
CP
$78.1B
$198K ﹤0.01%
2,500
+300
+14% +$22K
GPRE icon
3616
PUT
Green Plains
GPRE
$1.18B
$197K ﹤0.01%
7,800
-1,100
-12% -$29.1K
RVMDW icon
3617
Revolution Medicines Inc Warrant
RVMDW
$106M
$197K ﹤0.01%
+595,986
New +$266K
OPEN icon
3618
CALL
Opendoor
OPEN
$3.64B
$197K ﹤0.01%
45,363
CNXC icon
3619
CALL
Concentrix
CNXC
$1.5B
$196K ﹤0.01%
2,000
-600
-23% -$52.3K
AGNC icon
3620
CALL
AGNC Investment
AGNC
$12.4B
$196K ﹤0.01%
+20,000
New +$176K
DRIP icon
3621
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$98.4M
$196K ﹤0.01%
+1,737
New +$191K
JKHY icon
3622
CALL
Jack Henry & Associates
JKHY
$10.9B
$196K ﹤0.01%
1,200
+200
+20% +$30.6K
ITUB icon
3623
PUT
Itaú Unibanco
ITUB
$93.2B
$196K ﹤0.01%
31,951
+9,291
+41% +$49.3K
UPLD icon
3624
Upland Software
UPLD
$12.8M
$195K ﹤0.01%
4,617
-15,979
-78% -$691K
PSFE icon
3625
CALL
Paysafe
PSFE
$414M
$194K ﹤0.01%
+15,200
New +$168K

Similar funds

Walleye Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Walleye Capital held 5,834 positions worth $47.2B, up 21% from $39.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Walleye Capital deployed $2.33B of net new capital in Q4 2023, opening 1,032 new positions and adding to 1,743 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $59.4M trimmed.

  • Walleye Capital's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
  • Walleye Capital added most to Lam Research in Q4 2023, an estimated $51.4M increase.
  • Walleye Capital's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $59.4M.
  • Walleye Capital fully exited VMware, Inc in Q4 2023, selling an estimated $57.2M.
  • Walleye Capital's ten largest holdings make up 36% of its $47.2B portfolio in Q4 2023.
  • Walleye Capital opened 1,032 new positions and closed 961 in Q4 2023.
  • Walleye Capital's portfolio value rose 21% quarter-over-quarter to $47.2B.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.